Table 2.
The anti-cancer effects of major components of AL
Chemical name | Tumor suppressive effect | Potential targets | Function study | References |
---|---|---|---|---|
Atractylenolide I | Anti-bladder cancer effect | ↓PI3K/Akt/mTOR | In vitro and In vivo | [17] |
Anti-leukemia effect | ↑CD14/CD68 | In vitro | [23] | |
Anti-melanoma effect | ↓p-JAK2/p-STAT3 | In vitro | [25] | |
Atractylenolide II | Anti-melanoma effect | ↓p-STAT3/p-Src | In vitro and in vivo | [33] |
Anti-gastric cancer effect | ↓p-Akt/p-ERK | In vitro | [34] | |
Hinesol | Anti-leukemia effect | ↓c-Jun | In vitro | [50] |
β-Eudesmol | Anti-bile duct cancer effect | ↓NQO1 | In vitro and in vivo | [53, 54] |
β-Sitosterol | Anti-melanoma effect | ↓JNK | In vitro | [77] |
Anti-gastric cancer effect | ↑PTEN/p-AMPK | In vitro and in vivo | [78] |